Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
TAVR vs. surgery among intermediate-risk patients | AI helps novice sonographers shine | A question for CMS
Friday, July 7, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

TAVR vs. surgery: Exploring 5-year outcomes among intermediate-risk patients

A group of renowned TAVR specialists examined data from 783 pairs of intermediate-risk patients, sharing their findings in the Journal of the American College of Cardiology.

READ MORE >
Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.
Share on Twitter Share on Facebook Share on Linkedin

TAVR vs. surgery: Exploring 5-year outcomes among intermediate-risk patients

Share on Twitter Share on Facebook Share on Linkedin
Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.
A group of renowned TAVR specialists examined data from 783 pairs of intermediate-risk patients, sharing their findings in the Journal of the American College of Cardiology.
READ MORE >

AI can help novice sonographers deliver optimal echocardiograms

Roberto Lang, MD, has been closely involved with the development of AI technology that helps inexperienced ultrasound users perform high-quality echo exams. "It is an unbelievable thing when you see it working," he said. 

READ MORE >
Roberto Lang, MD, explains how AI can help novice users get diagnostic quality cardiac echo exams at ASE 2023.#ASE #AI #ASE2023
Share on Twitter Share on Facebook Share on Linkedin

AI can help novice sonographers deliver optimal echocardiograms

Share on Twitter Share on Facebook Share on Linkedin
Roberto Lang, MD, explains how AI can help novice users get diagnostic quality cardiac echo exams at ASE 2023.#ASE #AI #ASE2023
Roberto Lang, MD, has been closely involved with the development of AI technology that helps inexperienced ultrasound users perform high-quality echo exams. "It is an unbelievable thing when you see it working," he said. 
READ MORE >

Interventional cardiologists, electrophysiologists ask CMS to clarify policy after unexpected denials

Three cardiology societies have reached out to CMS with questions about how MACs are interpreting a policy related to shared decision-making. 

READ MORE >
The Society for Cardiovascular Angiography and Interventions (SCAI), American College of Cardiology (ACC) and Heart Rhythm Society (HRS) have asked the U.S. Centers for Medicare and Medicaid Services (CMS) to clarify a key detail related to the national coverage determination (NCD) for percutaneous left atrial appendage closure (LAAC).
Share on Twitter Share on Facebook Share on Linkedin

Interventional cardiologists, electrophysiologists ask CMS to clarify policy after unexpected denials

Share on Twitter Share on Facebook Share on Linkedin
The Society for Cardiovascular Angiography and Interventions (SCAI), American College of Cardiology (ACC) and Heart Rhythm Society (HRS) have asked the U.S. Centers for Medicare and Medicaid Services (CMS) to clarify a key detail related to the national coverage determination (NCD) for percutaneous left atrial appendage closure (LAAC).
Three cardiology societies have reached out to CMS with questions about how MACs are interpreting a policy related to shared decision-making. 
READ MORE >

Featured Articles

New ‘zero-contrast’ TAVR technique shows promise in pilot study

Researchers think this new technique could be beneficial for patients presenting with both severe symptomatic aortic stenosis and chronic kidney disease. 

READ MORE >
No contrast transcatheter aortic valve replacement
Share on Twitter Share on Facebook Share on Linkedin

New ‘zero-contrast’ TAVR technique shows promise in pilot study

Share on Twitter Share on Facebook Share on Linkedin
No contrast transcatheter aortic valve replacement
Researchers think this new technique could be beneficial for patients presenting with both severe symptomatic aortic stenosis and chronic kidney disease. 
READ MORE >

All eyes are on hypertrophic cardiomyopathy now that a drug treatment is in place

Ted Abraham, MD, explained why HCM has entered the limelight at recent cardiology conferences, including ASE 2023.

READ MORE >
Ted Abraham, MD, explains ASE efforts to increase HCM education and standardization of care. #HCM #ASE #ASE23 #ASE2023
Share on Twitter Share on Facebook Share on Linkedin

All eyes are on hypertrophic cardiomyopathy now that a drug treatment is in place

Share on Twitter Share on Facebook Share on Linkedin
Ted Abraham, MD, explains ASE efforts to increase HCM education and standardization of care. #HCM #ASE #ASE23 #ASE2023
Ted Abraham, MD, explained why HCM has entered the limelight at recent cardiology conferences, including ASE 2023.
READ MORE >

FDA approves world’s first dual-chamber leadless pacemaker system

The minimally invasive system is made up of two pacemakers that send signals back and forth to one another. One pacemaker is placed on the patient's right ventricle, and the other is placed on the patient's right atrium. 

READ MORE >
FDA approves Abbott’s Aveir dual chamber (DR) leadless pacemaker system, the world’s very first dual chamber leadless pacing solution for treating patients with abnormal heart rhythms.
Share on Twitter Share on Facebook Share on Linkedin

FDA approves world’s first dual-chamber leadless pacemaker system

Share on Twitter Share on Facebook Share on Linkedin
FDA approves Abbott’s Aveir dual chamber (DR) leadless pacemaker system, the world’s very first dual chamber leadless pacing solution for treating patients with abnormal heart rhythms.
The minimally invasive system is made up of two pacemakers that send signals back and forth to one another. One pacemaker is placed on the patient's right ventricle, and the other is placed on the patient's right atrium. 
READ MORE >

In Case You Missed It

Private equity-backed cardiology group continues busy year with acquisition of Florida practice

Cardiovascular Associates of America, which has already had an eventful 2023, announced a new acquisition that helps expand its footprint in the Sunshine State. 

READ MORE >
business news announcement
Share on Twitter Share on Facebook Share on Linkedin

Private equity-backed cardiology group continues busy year with acquisition of Florida practice

Share on Twitter Share on Facebook Share on Linkedin
business news announcement
Cardiovascular Associates of America, which has already had an eventful 2023, announced a new acquisition that helps expand its footprint in the Sunshine State. 
READ MORE >

How to encourage shared decision-making when treating aortic stenosis

Diagnosing, treating and managing aortic stenosis is often a challenging task, especially when the patient has a long life expectancy. Shared decision-making can make a significant impact, helping ensure the patient's values and preferences are taken into consideration. 

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

How to encourage shared decision-making when treating aortic stenosis

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Diagnosing, treating and managing aortic stenosis is often a challenging task, especially when the patient has a long life expectancy. Shared decision-making can make a significant impact, helping ensure the patient's values and preferences are taken into consideration. 
READ MORE >

In Other News

Preop prostate MRI findings predict cancer recurrence at rates similar to pathology, analysis shows

Given the similarities in accuracy between pathology results and preoperative imaging, MRI could have a greater role in risk assessments in the future, experts suggested in AJR.

READ MORE >
An international panel of experts recently developed and validated a reporting assessment scoring system that analyzes the location and extent of prostate cancer recurrence. 
Share on Twitter Share on Facebook Share on Linkedin

Preop prostate MRI findings predict cancer recurrence at rates similar to pathology, analysis shows

Share on Twitter Share on Facebook Share on Linkedin
An international panel of experts recently developed and validated a reporting assessment scoring system that analyzes the location and extent of prostate cancer recurrence. 
Given the similarities in accuracy between pathology results and preoperative imaging, MRI could have a greater role in risk assessments in the future, experts suggested in AJR.
READ MORE >

Spotify CEO and founder launches whole-body imaging startup with $65M in investor financing

Neko Health was first launched in 2018 and has experienced “overwhelming demand” since then, with long wait lists for its service.

READ MORE >
Neko Health founders
Share on Twitter Share on Facebook Share on Linkedin

Spotify CEO and founder launches whole-body imaging startup with $65M in investor financing

Share on Twitter Share on Facebook Share on Linkedin
Neko Health founders
Neko Health was first launched in 2018 and has experienced “overwhelming demand” since then, with long wait lists for its service.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup